Resources
- sort by:
- Relevance
- Date
- Popularity
- Merck Announces First Quarter Earnings Per Share Guidance and Raises Full-Year 2007 Earnings Per Share Guidance
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. announced today that it anticipates its first-quarter earnings per share EPS will be $0.63 to $0.67, excluding restructuring charges related to site closures and position eliminations, and anticipates reported first-quarter EPS of $0.58 to $0.64. Merck attributed these anticipated results to early...
- Research articles 2007-02-28
- Merck Anticipates Higher Than Expected First Quarter Results; Reaffirms Full-Year 2005 Earnings Per Share Guidance
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. announced today that it anticipates its first quarter earnings per share EPS will be 62 cents, subject to final review of its first quarter results. Merck attributed these anticipated results to a number of factors including ongoing cost management, the favorable impact...
- Research articles 2005-04-13
- Merck Anticipates Higher Than Expected First-Quarter Results; Raises Full-Year 2007 Earnings Per Share Guidance
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. announced today that, subject to final review of its first-quarter results, it anticipates its first-quarter earnings per share EPS will be $0.84, excluding restructuring charges related to site closures and position eliminations, and its reported EPS will be $0.78. Merck attributed these...
- Research articles 2007-04-12
- Merck Reports Double-Digit Revenue and Earnings-Per-Share Growth for Third-Quarter 2007
- * Company Announces Third-Quarter 2007 Earnings Per Share EPS of $0.75, Excluding Restructuring Charges; Third-Quarter Reported EPS of $0.70
- Research articles 2007-10-22
- ADDING and REPLACING Merck Announces Second-Quarter 2004 Earnings Per Share -EPS- of 79 Cents
- WHITEHOUSE STATION, N.J. -- ADD after Earnings Conference Call and prior to Merck Financial Guidance for 2004, the following:
- Research articles 2004-07-21
- Applera Corporation F1Q08 (Qtr End 9/30/07) Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you sir. [Operator’s instructions.] One moment while we compile a list of questions. Our first question will come from the line of Ross Muken of Deutsche Bank, please proceed. Ross Muken – Deutsche Bank Good morning everyone. Mark P. Stevenson –...
- Earnings calls 2007-10-25
- Biomet F3Q06 (Qtr Ending Feb 28, 2006) Earnings Conference Call Transcript (BMET)
- Earnings Call Excerpt Biomet, Inc. BMET Q3 2006 Earnings Conference Call March 21, 2006, 10:00 a.m. EST Executives: Dane A. Miller, Ph.D., President and Chief Executive Officer Bart J. Doedens, M.D., Vice President, Biomet, Inc., President, EBI, L.P. Gregory D. Hartman, Senior...
- Earnings calls 2006-03-21
- Merck Anticipates Higher Than Expected First-Quarter Results; Reaffirms Full-Year 2006 Earnings Per Share Guidance
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. announced today that it anticipates its first-quarter EPS will be $0.71 to $0.75, excluding restructuring charges, and anticipates reported first-quarter EPS of $0.61 to $0.67. Merck attributed these anticipated results to strong ZOCOR revenue performance in the first quarter and the timing...
- Research articles 2006-04-04
- Merck Announces Second-Quarter 2002 Earnings Per Share of 77 Cents; Merck's Five Largest Products Collectively Achieve Sales Growth of 14% Over Second-Quarter 2001
- Business Editors and Medical/Health Writers
- Research articles 2002-07-19
- Merck Anticipates Full-Year 2005 Earnings Per Share Range of $2.42 to $2.52; Reaffirms Fourth-Quarter and Full-Year 2004 EPS Guidance
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc.
- Research articles 2004-12-08
- Sale of Health Division Dilutes Earnings of Green Bay, Wis.-Based Retail Chain.(Knight Ridder/Tribune Business News)
- Aug. 16--GREEN BAY, Wis.--Shopko Stores Inc. announced diluted earnings per share for the 13 weeks ended July 29 of 25 cents before special charges and the gain on the sale of ProVantage stock. Due to the sale of ProVantage Health Services Inc. to Merck &...
- Research articles 2000-08-16
- Merck Announces Strong Financial Results for the Third Quarter 2006 Led by the Performance of SINGULAIR, VYTORIN and Vaccines
- * Company Posts Third-Quarter Earnings Per Share EPS of 51 Cents, Including the Impact of Reserving an Additional $598 Million Solely for Future VIOXX Legal Defense Costs and Excluding Restructuring Charges; Reported Third-Quarter EPS of 43 Cents
- Research articles 2006-10-20
- ImClone Systems Inc. Q3 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator [Operator Instructions]. Your first question comes from May-Kin Ho of Goldman Sachs. May-Kin Ho - Goldman Sachs Hi. I guess, I wanted to ask question about really how your payment from Bristol would be recognized and how we should going forward project out...
- Earnings calls 2007-10-25
- Neurogen Corporation Q2 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you. Operator instructions And our first question comes from the line of Kim Lee with Pacific Growth Equities. Please proceed. Kim Lee – Pacific Growth Equities Good morning. Steve Davis Good morning, Kim. Kim Lee – Pacific Growth Equities Two questions. First,...
- Earnings calls 2008-09-02
- Caterpillar Blows Out Earnings Through Lower Costs
- Ockham Research submits: The stock market is pointed higher on Tuesday morning in large part because of five Dow components reporting earnings that have beaten expectations. Coca-Cola KO, DuPont DD, Caterpillar CAT, United Technologies UTX, and Merck MRK all reported earnings today and each of these stocks are...
- External links 2009-07-21
- DaimlerChrysler Q2 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Friedrich Lauer We take the first question from Johan Grabe, please. Johan Grabe - Deutsche Bank Yes, good afternoon. Johan Grabe, Deutsche Bank. Three questions if I may. First of all on Mercedes on your updated margin guidance I wonder whether you could provide the...
- Earnings calls 2007-07-25
- Pharmaceutical Product Development, Inc., 2009 Guidance Call Transcript
- Earnings Call ExcerptPharmaceutical Product Development, Inc. PPDI 2009 Guidance Call January 15, 2009 9:00 am ET Executives Dr. Fredric N. Eshelman - Vice Chairman and Chief Executive Officer Daniel G. Darazsdi - Chief Financial Officer William J. Sharbaugh - Chief Operating Officer Analysts John Kreger - William...
- Earnings calls 2009-01-15
- Merck Continues to Anticipate Earnings Per Share Growth in 2007; Reaffirms Long-Term, Double-Digit Compound Annual EPS Growth from 2005 to 2010, Excluding One-Time Items and Restructuring Charges
- * Full-Year 2006 Anticipated EPS Range of $2.48 to $2.52, Excluding Restructuring Charges; Reported 2006 EPS Range of $2.18 to $2.25
- Research articles 2006-12-06
- Dynavax Technologies Corporation Q4 2007 Earnings Call Transcript
- Question-and-Answer Session Operator Thank you. Operator Instructions. We will take our first question from Bret Holley with Oppenheimer & Company. Bret Holley Yeah, hi. Thanks for taking my questions. I had a question about any additional market research you have done following the Merck...
- Earnings calls 2008-02-19
- J&J to Slash 7,000 to 8,000 Jobs
- NEW YORK (Reuters) - Johnson & Johnson said on Tuesday it plans to cut 6 percent to 7 percent of its workforce in a battle to prop up profits in the face of generic competition to its prescription drugs. The company said the cuts will affect 7,000 to 8,000 jobs,...
- News items 2009-11-03
- << Previous
- page 1 of 2
- Next >>
